Triptolide inhibits cell growth and induces G0-G1 arrest by regulating P21wap1/cip1 and P27 kip1 in human multiple myeloma RPMI-8226 cells

Chinese Journal of Cancer Research

Volumn 22, Issue 2, 2010, Pages 141-147

  Liu, Yuan ^a   Zeng, Ling Lan ^a   Chen, Yan ^a   Zhao, Fei ^a   Li, Rui ^a   Zhang, Chun ^a   Wen, Lu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cell cycle; Multiple myeloma; RPMI 8226 cells; Triptolide

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; TRIPTOLIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 77954678060     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-010-0141-5     Document Type: Article

References (25)

1. Lou YJ, Jin J. Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogennous leukemia cells[J]. Leuk Lymphoma 2004; 45: 373-376
2. Tang XY, Zhu YQ, Tao WH, et al. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma[J]. Postgrad Med J 2007; 83: 338-343
3. Jan HJ, Lee CC, Lin YM, et al. Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells[J]. Cancer Lett 2009; 277: 141-148
4. Liang M, Fu J. Triptolide inhibits interferon-gammainduced programmed death-1-ligand 1 surface expression in breast cancer cell[J]. Cancer Lett 2008; 270: 337-341
5. Philips PA, Dudeja V, McCarroll JA, et al. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70[J]. Cancer Res 2007; 67: 9407-9416
6. Roy S, Gu M, Ramasamy K, et al. p21/Cip1 and p27/Kip1 are essential molecular targets of inositol hexahosphate for its antitumor efficacy against prostate cancer[J]. Cancer Res 2009; 69: 1166-1173
7. Baiz D, Pozzato G, Dapas B, et al. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels[J]. Biochimie 2009; 91: 373-382
8. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond[J]. Dev Cell 2008; 14: 159-169
9. Gao F, Yi J, Yuan JQ, et al. The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen species[J]. Cell Res 2004; 14: 81-85
10. Carter BZ, Mak DH, Schober WD, et al. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemia cells[J]. Blood 2006; 108: 630-637
11. Krug U, Ganser A, Koeffler HP. Tumor suppressor genes in normal and malignant hematopoiesis[J]. Oncogene 2002; 21: 3475-3495
12. Zanetti M, Stocca A, Dapas B, et al. Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose[J]. J Mol Med 2008; 86: 185-195
13. Singh RP, Agarwal R. Natural flavonoids targeting deregulated cell cycle progression in cancer cells[J]. Curr Drug Targets 2006; 7: 345-354
14. Athar M, Back JH, Kopelovich L, et al. Multiple, molecular targets of resveratrol: anti-carcinogenic mechanisms[J]. Arch Biochem Biophys 2009; 486: 95-102.
15. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment[J]? Trends Cell Biol 2003; 13: 65-70.
16. Tian Y, Song Y. Effects of inositol hexaphosphate on proliferation of HT-29 human colon carcinoma cell line[J]. World J Gastroenterol 2006; 12: 4137-4142
17. Roy S, Singh RP, Aqarwal C, et al. Downregulation of both p21/Cip1 and p27/kip1 produces a more aggressive prostate cancer phenotype[J]. Cell Cycle 2008; 7: 1828-1835.
18. Enders GH, Maude SL. Traffic safety for the cell: influence of cyclin-dependent kinase activity on genomic stability[J]. Gene 2006; 371: 1-6.
19. Schwartz GK, Shah MA. Targeting the cell cycle: a new approach to cancer therapy[J]. J Clin Oncol 2005; 23: 9408-9421
20. Zheng JY, Wang WZ, Li KZ, et al. Effect of p27(kip1) on cell cycle and apoptosis in gastric cancer cells[J]. World J Gastroenterol 2005; 11: 7072-7077
21. Laochim E, Michael M, Stavropoulos NE, et al. Expression patterns of cyclinD1, E and cyclindependent kinase inhibitors p21wap1/Cip1 and p27/Kip1 in Urothelial carcinoma: Correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features[J]. Urol Int 2004; 73: 65-73.
22. Korkolopoulou P, Christodoulou P, Konstantinidou AE, et al. Cell cycle regulators in bladder cancer: A multivariate survival study with emphasis on p27kip1[J]. Hum Pathol 2000; 31: 751-760
23. Katner AL, Hoang QB, Gootam P, et al. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing P27kip1[J]. Prostate 2002; 53: 77-87. (Pubitemid 34966867)
24. Onumah OE, Jules GE, Zhao Y, et al. Overexpression of catalase delays G0- G1 to S phase transition during cell cycle progression in mouse aortic endothelial cells[J]. Free Radic Biol Med 2009; 46: 1658-1667
25. Roy S, Kaur M, Aqarwal C, et al. p21 and p27 induction by silibinin is essential for its cellcycle arrest effect in prostate carcinoma cells[J]. Mol Cancer Ther 2007; 6: 2696-2707